Crossmark

Role and molecular mechanisms of HuangQiSiJunZi decoction for treating triple-negative breast cancer as explored via network pharmacology and bioinformatics analyses

Crossref DOI link: https://doi.org/10.1186/s12885-024-12957-5

Published Online: 2024-09-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Decai

Xie, Dongqing

Meng, Shuai

MI, Jiwei

Wang, Haiming

Li, Lingsheng

Zhang, Yin

Cui, Yixin
License Information

Text and Data Mining valid from 2024-09-30

Version of Record valid from 2024-09-30
More Information

Article History

Received: 23 April 2024

Accepted: 17 September 2024

First Online: 30 September 2024

Declarations

:

: The study was conducted using established cell lines exclusively. No human or animal subjects were involved in this research. Therefore, ethical approval from an Institutional Review Board (IRB) or Ethics Committee was not required.All cell lines used in this study were obtained from reliable and certified sources, and were handled in accordance with institutional guidelines and regulations.The authors declare no ethical conflicts associated with this research.

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below